Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SPRINT.ST Gross Margin

The Gross Margin of Sprint Bioscience AB (SPRINT.ST) is 56.83%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

SPRINT.ST Gross Margin - Historical Value
Date Value
2024-12-31 56.83%
2023-12-31 82.77%
2022-12-31 -15478.31%
2021-12-31 70.28%
2020-12-31 38.06%
2019-12-31 75.63%
2018-12-31 41.89%
2017-12-31 87.53%
2016-12-31 98.80%
2015-12-31 102.69%
SPRINT.ST Gross Margin - Peers Comparison